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Background: Traditional repair of aortic arch aneurysms requires cardiopulmonary bypass, hypothermia, and circulatory
arrest and is associated with considerable morbidity and mortality. Endovascular stent-graft placement has developed as
a safe and effective treatment for various diseases of the descending aorta and, recently, even in delicate anatomic regions
such as the aortic arch. The aim of this study is to review our clinical experience with endovascular treatment of aortic arch
aneurysms after surgical transposition of supra-aortic vessels.
Methods: Fifteen patients received thoracic stent-graft implants after aortic debranching for repair of aortic arch aneurysms
during the 3-year period ending December 31, 2005. All patients were not candidates for standard endovascular repair
due to inadequate proximal landing zones on the aortic arch. Device design and implant strategy were determined by an
evaluation of aortic morphology with angiography and computed tomography (CT) scanning. Stent-grafts were used to
repair the arch after supra-aortic vessel transposition was performed. The endografts were implanted transfemorally or via
an iliac Dacron conduit graft using standardized endovascular techniques. Follow-upwas 100% complete (mean, 18 2.5
months; range, 12 to 36 months). Outcome variables included death and treatment failure (endoleak, aortic rupture,
reintervention, or aortic-related or sudden death). Follow-up included clinical examination, chest radiograph, and CT at
discharge, 6 months after stent-graft placement, and yearly thereafter.
Results: Stent-graft deployment success was 100% after staged supra-aortic vessel transposition. Patency of all endografts
and conventional bypasses was 100%. No endoleak or graft migration was observed. There were no neurologic
complications. One patient died 2 months after the procedure from pulmonary complications.
Conclusion: Repair of aortic arch aneurysms by sequential transposition of the supra-aortic branches and endovascular
stent-graft placement is feasible. Extended application of this technique will enable safe and effective treatment of a highly
selected subgroup of patients with aortic aneurysms by avoiding conventional arch aneurysm repair in deep hypothermia
and circulatory arrest. ( J Vasc Surg 2006;44:460-6.)Thoracic aortic aneurysm is a life-threatening condition
with an estimated incidence of 6 to 10 cases per 100,000
person-years.1 The natural history of untreated patients
with thoracic aortic aneurysms is characterized by progres-
sive expansion and eventual rupture.2,3 Five-year survival in
patients with untreated thoracic aortic aneurysms has been
estimated at 15% to 55%.2,3
Traditional treatment of patients with thoracic aortic
aneurysms is open surgical graft replacement.4 Despite
progressive surgical advances, conventional surgical repair
is still associated with substantial morbidity and mortality,
especially in elderly patients with other major medical con-
ditions and in cases of emergent operation for aortic rup-
ture.5-8 A perioperative death rate of 10%, a risk of
paraplegia of 4% to 5%, and a long recovery from thoracot-
omy make this a weighty undertaking for the surgeon and
the patient alike.9,10
Endovascular repair of thoracic aortic pathology is on
an evolutionary threshold. Advancing technologies and
techniques of thoracic endografting now combine to offer
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460treatment to a greater number of patients with severe
thoracic aortic lesions and comorbidities. Endovascular
stent-graft repair of descending thoracic aortic aneurysms
currently offers the benefit of aneurysm exclusion without
the physiologic insult of prolonged proximal aortic clamp-
ing and direct surgical exposure, which may improve early
morbidity.11,12
Aortic arch aneurysms present a particular challenge to
endovascular repair due to the involvement of supra-aortic
vessels, the anatomic curvature of the arch, the high blood
flow in the area, and substantial movement of this portion
of the aorta with each heartbeat. A variety of maneuvers
have been recommended to address the landing zone lim-
itations to thoracic endografting imposed by the arch ves-
sels, including transostial bare-stent placement, intentional
occlusion of arch vessel origins, and vessel transposition or
bypass grafting. These adjunctive techniques can help ex-
tend the option of this minimally invasive treatment to a
greater number of patients with severe thoracic aortic le-
sions and comorbidities that place them at high risk for
standard surgical intervention.13
This report presents the results of a review of our 3-year
clinical experience with endovascular treatment of aortic
arch aneurysms after surgical transposition of supraaortic
vessels (Fig 1).
PATIENTS AND METHODS
Fifteen patients underwent surgical transposition of
supra-aortic vessels and thoracic stent-graft implantation
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ending December 31, 2005 (Table I). They represent 83%
of 18 patients referred to the senior author (I.L.) for
possible endovascular repair of arch aneurysms during the
same time interval. Three patients were excluded from
consideration of endovascular treatment: Two patients had
small or diseased access iliac arteries, and one patient had
extensive aneurysmal disease with aneurysm involvement of
the ascending aorta without identifiable proximal “landing
zones” for endograft attachment and seal. Cardiovascular
surgeons referred 80% of the patients after operative inter-
vention was excluded because of very high surgical risk
Fig 1. Schematic of the hybrid treatment with transposition of
epiaortic vessels, banding of ascending aorta and deployment of an
endograft.(American Society of Anesthesiologists category 4). Allpatients signed an institutional approved informed consent
and were made fully aware of the investigational nature of
endovascular treatment.
Thirteen patients had aortic arch aneurysms extending
into the descending thoracic aorta, and two patients had
isolated aortic arch aneurysms. Aneurysms were considered
for repair when one or more of the following were present:
symptoms (pain) (3 patients), maximum diameter of the
sac 5.0 cm, or aneurysm diameter more than twice the
diameter of an adjacent nonaneurysmal segment of the
thoracic aorta (12 patients). The mean size of repaired
aneurysms was 6.8 1.1 cm (range, 5.2 to 10.7 cm). Men
outnumbered women (60% vs 40%), and the average age
was 74 years (range, 37- 88 years).
All patients were not candidates for standard endovas-
cular thoracic aneurysm repair due to inadequate proximal
landing zones on the aortic arch. Patient characteristics are
summarized in Table I. Patient evaluation and selection,
and both stages of the repair involved both cardiovascular
surgeons and interventional radiologists. Outcome vari-
ables assessed included death and treatment failure, consist-
ing of endoleak, aortic rupture, reintervention, or aortic-
related or sudden death.
Preprocedural imaging. All patients underwent spiral
computed tomographic angiography (CTA) scanning with
three-dimensional reconstruction and calibrated aortogra-
phy before stent-graft placement to determine the location,
length, and diameter of the aneurysm and the possible
stent-graft landing zones, as well as to evaluate the suitabil-
ity of the iliac and femoral arteries for vascular access.
Stent-graft dimensions were calculated from the CTA im-
ages. Graft diameters were oversized by 10% to 15% com-
pared with the landing zone diameters, and graft lengths
were at least 30 to 40 mm longer than the target lesion
length to ensure adequate wall contact and a tight circum-
ferential seal in the landing zones. Preprocedural angiogra-
phy was done to confirm aneurysm morphology, adequacy
of the iliofemoral access sites, and assess the patency and
dominance of the vertebral arteries as well as the anatomy of
the circle of Willis in order to define what to do with the left
subclavian artery (LSA).
Stage 1 procedure. The first stage of the procedure
Table I. Demographic and clinical characteristics
N %
Patients 15 100
Gender
Male 9 60
Female 6 40
Age (years)
Mean 74
Range 37-88
Diabetes 9 60
Tobacco use 10 66
Hypertension 13 86
Hyperlipidemia 8 53
The mean aneurysm size was 6.8 cm (range, 5.2-10-7).was surgical debranching of the aortic arch and relocation
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cardiovascular surgeons including the author (H.S.). Addi-
tionally, banding of the distal segment of the ascending
aorta was done to facilitate secure fixation of the endograft
in the proximal landing zone, prevent further dilatation of
the aorta, and possibly limit graft migration. In addition,
banding allowed insertion of radiopaque markers to facili-
tate the appropriate deployment of the endograft and min-
imize the amount of contrast material used during the
stent-graft procedure. The procedure was performed under
general anesthesia, supplemented by epidural analgesia.
Cerebral activity was monitored by means of continuous
intraoperative electroencephalography (EEG).
After a median sternotomy, the pericardium was
opened and the ascending aorta was exposed in the usual
fashion. The left brachiocephalic vein was then circumfer-
entially dissected, beginning from the confluence of the left
internal jugular vein and the left subclavian vein up to the
superior vena cava. The brachiocephalic trunk, the left
common carotid, and the left subclavian arteries were also
circumferentially dissected. After systemic heparinization
Fig 2. The first stage of the procedure is surgical debranching of
the aortic arch and relocation of the supra-aortic branches. To
further optimize the proximal landing zone we later developed
surgical banding of the ascending aorta distal to tube-graft epiaor-
tic vessel transposition.(80 U/kg), the ascending aorta was side-clamped, and aproximal end-to-side anastomosis was performed with a
bifurcated 14  7 mm Dacron graft (Platinum, Hemash-
ield, Boston Scientific Corp, Natick,Mass), positioned with
the limbs facing up using a 4-0 Prolene (Ethicon, Inc,
Somerville, NJ) running suture.
Consecutively, the brachiocephalic trunk was then par-
tially clamped, longitudinally opened, and an end-to-side
anastomosis performed with the initial branch of the bifur-
cated prosthesis using 5-0 Prolene running suture. After
flushing, blood flow was re-established. The brachioce-
phalic trunk was then ligated. The left common carotid
artery was then test-clamped, and if no anomalies were
recorded by EEG, the artery was ligated proximally and an
end-to side anastomosis done with a branch of the bifur-
cated graft using a 5-0 Prolene running suture. After flush-
ing, blood flow was re-established.
Because stent-graft coverage and exclusion of the left
subclavian artery is safe in the absence of right vertebral
artery occlusion or prior left internal mammary artery
(LIMA) bypass13,14 and with a documented intact verte-
brobasilar system, left carotid subclavian bypass was done
only in the presence of right vertebral artery occlusion or a
prior LIMA. However, aneurysmal involvement or an an-
eurysm close to the left subclavian artery posses a potential
for reflux endoleak and ligation of the left subclavian artery
is mandatory in such cases.
A proximal neck of sufficient length was thus obtained
in the proximal arch and ascending aorta for endovascular
stent grafting (Fig 2). Banding of this neck was done by
circumferential dissection of 2 to 3 cm of the ascending
aorta just proximal to aneurysm (distal part of the ascend-
ing aorta just distal to the ligated brachiocephalic artery).
Circumferential coverage of that part of the ascending aorta
by a Dacron patch was done without tension using 5-0
Prolene suture. Banding of the ascending aorta was done in
all patients. Specific technical aspects of stage I procedures
are listed in Table II (online only).
Stage 2 procedure. Although relocation of supra-
aortic branches and aortic endografting could both be done
in one stage, we prefer to do the endovascular part sepa-
rately in the cardiovascular interventional lab where better
imaging facilities for endografting are available. However,
to reduce the risk of rupture of the thoracic aneurysm
during the interval between the two stages, the (endovas-
cular) second stage of the procedure was planned 2 to 3
weeks after the first stage.
Second stage procedures were done using local anes-
thesia in three cases, epidural anesthesia in nine, and gen-
eral anesthesia in three. The anesthesiologist was asked to
control the blood pressure pharmacologically if necessary,
maintaining the mean pressure at 80 mm Hg.
Endovascular access was achieved with femoral cut-
down in 12 patients and a temporary iliac conduit in three.
After preliminary angiography to ensure patency of the
previous bypass grafts, the common femoral artery was
exposed in the groin and cannulated. After systemic anti-
coagulation with 80U/kg of heparin, a standard guidewire
was advanced into the ascending aorta and replaced with an
m aft
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Corp). Always taking much care to keep the tip of the wire
in the ascending aorta and not allowing it to reach the heart
to avoid life-threatening arrhythmias, the endograft was
then advanced up to the ascending aorta. The endograft
was then deployed, which completely excluded the aneu-
rysm (Fig 3).
Completion aortography performed from the ascend-
ing aorta, which had been cannulated through the right
brachial artery and the bypass graft, showed a satisfactory
result in all patients as evidenced by regular perfusion of the
supraaortic reconstruction and no signs of endoleak. Ad-
junctive techniques to prevent paraplegia, such as spinal
fluid drainage, were not used in any patient during this
experience.
Talent stent-grafts (Medtronic Europe SA, Tolochenaz,
Switzerland) custom-made to fit the differing dimensions of
the ascending and descending aorta were used in all patients.
Proximal endograft attachment was in the ascending aorta in
11 patients and in the aortic arch in four. Distal stent graft
attachment was in the supradiaphragmatic descending tho-
racic aorta in 13 patients and within the proximal abdominal
aorta above the celiac artery origin in two.
Stent-graft configuration was a single segment in three
patients, two overlapping segments in nine, and three seg-
ments in three. The Talent thoracic delivery system used in
our experience was relatively stiff and presented a technical
challenge at the time of deployment when the delivery
sheath was bent across the aortic arch. In all cases, to
facilitate stent-graft deployment, a gentle curve in the prox-
imal part of the delivery system was made to facilitate
Fig 3. A and B, Angiograsubsequent advancement across the aortic arch. These ma-neuvers are difficult, and potentially troublesome; however,
no apparent complications could be attributed to them.
Specific technical aspects of stage II procedures are listed in
Table III (online only).
Follow-up. Length of follow-up a mean of 18  2.5
months (range, 12 to 36 months) and was complete in all
patients. Patient surveillance involved clinical examination,
contrast and noncontrast CT scan, and plain-film radiographs
of the stent-graft device before hospital discharge, 6 months
later, and yearly thereafter. Device migration andmetal-frame
integrity were assessed. Follow-up clinical status was obtained
by contacting all surviving patients or family members and
their primary care physician. Cause of death was determined
from death certificates, and medical records.
Definitions. Primary success was complete exclusion
of the aneurysmal sac without any additional intervention.
Secondary success was complete exclusion of the aneurysm
after secondary intervention. Endoleak was radiologic evi-
dence of blood flow outside the stent graft and was classi-
fied as primary (diagnosed 30 days of endovascular re-
pair) or secondary (diagnosed30 days after intervention).
Aortic reintervention was the need for any surgical or
endovascular interventions on the treated aortic segment
during follow-up. Treatment failure was a broad, all-
inclusive composite end point including (1) perioperative
death, (2) endoleak, (3) aortic reintervention, (4) aortic-
related death, and (5) all sudden, unexplained late deaths.
RESULTS
Procedure and hospital course. The second stage of
the procedure was done 2 to 3 weeks after the first stage in
er endograft implantation.13 patients and after 6 weeks in two patients because of the
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mean time for the stage I surgical debranching procedure
was 95 minutes (range, 80 to 130 minutes). Aortic side
clamping was done in all cases during aortic anastomoses.
In seven patients, the brachiocephalic trunk was also large
enough to allow side clamping, but total clamping was
done in the other eight patients. No shunts were used
because there were no EEG changes on either brachioce-
phalic or left carotid artery clamping. Left carotid subcla-
vian bypass/transposition was done in three patients, one
for right vertebral occlusion and two for previous LIMA.
Proximal ligation of the left subclavian artery alone was
done in the remaining 12 patients.
The mean time for the stage 2 endovascular procedure
was 110 minutes (range, 35 to 170 minutes). The stent-
graft was deployed successfully in all patients, with no
surgical conversions. The primary success rate was 100%.
No endoleaks were detected in the perioperative period,
and no secondary reinterventions were required. No neu-
rologic complications (paraplegia or stroke) occurred.
Postoperative CT showed satisfactory placement of the
endograft with complete thrombosis of the aneurysmal sac
(Fig 3). The overall hospital stay for the 2 stages was 8 to 17
days.
Perioperative adverse events. Four patients (26%)
had nonfatal morbid adverse events 30 days. These in-
volved access-site femoral artery thrombosis that was
treated with surgical thrombectomy and endarterectomy
and patch angioplasty in one patient, “postimplant syn-
drome” with severe back pain, fever, leukocytosis, and
decreased platelet count lasting several days in two, and
lymph leakage from a cervical incision after a preliminary
subclavian-to-carotid transposition in one. One patient
died 2 months after the procedure from pulmonary com-
plications (pneumonia).
Follow-up:No other mortalities were observed during
the follow-up. Patency of all endografts and conventional
bypasses during follow-up was 100%. No endoleaks were
detected, and no surgical or endovascular reinterventions
were needed during the follow-up period. No instances of
graftmigrationor aortic rupturewere observed. In all patients,
follow-up CT scans showed progressive regression of aneu-
rysm diameter size of 7 to 10mmafter 6months and 13 to 15
mm after 1.5 years. The diameter of the banded segment of
the ascending aorta remained constant throughout the fol-
low-up period (Fig 4).
DISCUSSION
The often-quoted 6-cm-diameter threshold before
consideration of elective repair of a thoracic aortic aneu-
rysm likely reflects surgeon reluctance to recommend tho-
racic aortic replacement because of the risks of serious
morbidity and mortality.11 However, the natural history of
thoracic aortic aneurysm is similar to if not worse than that
of abdominal aortic aneurysm, with a rupture rate of 14%
2 years reported for aneurysms with a diameter of 5.0cm, or twice the size of an adjacent nonaneurysmal segment
of aorta.15
Hypothermic circulatory arrest is the traditional
method to treat aortic arch aneurysms, but deep hypother-
mia is associated with prolonged extracorporeal circulation
and increased mortality and morbidity rates due to micro-
emboli production and a total body inflammatory reaction,
particularly coagulopathy, and respiratory distress, as well
as renal, cardiac, and endothelial dysfunction.16,17 Thus, an
alternative method that avoids cardiopulmonary bypass
(CPB) and hypothermic circulatory arrest would clearly
benefit the patient.
Endovascular grafting could be a safe and effective
alternative to conventional surgical treatment of aneurysms
of the aortic arch, partly because it avoids CPB. The prob-
lem of the lack of an adequate proximal neck for safe
fixation of the endograft may be solved by “lengthening the
branchless descending thoracic aorta” by means of surgical
relocation of the supra-aortic vessels.
In 1998, Buth et al18 reported retrograde endovascular
grafting of the distal aortic arch after ascending aorta-to-left
common carotid and left subclavian artery bypass with a
bifurcated graft. In 2002, Criado11 reported a completely
extrathoracic revascularization of the supra-aortic vessels
before aortic endografts by using the femoral artery as the
inflow vessel. However, the ascending aorta may be a safer
and more durable source of inflow to the cerebral vessels
that are relocated. According to their map of the aortic
arch, the zone proximal to the brachiocephalic trunk (zone
0) is technically the most challenging.
Other authors have also reported debranching the aor-
tic arch to enable a stent-graft to land in zone 0 of the aortic
arch. In 2003, Nitta et al19 reported revascularization of
the supra-aortic vessels with a trifurcated graft from the
ascending aorta performed under extracorporeal circula-
tion and antegrade cerebral perfusion. This does not seem
to us to be necessary, because a temporary occlusion of one
of the supra-aortic vessels is usually well tolerated, and an
intraluminal shunt can be used if an EEG shows inadequate
tolerance by the brain.
A complex case of repair of a ruptured aortic arch
aneurysm in a very sick patient was reported by Drenth et al
in 2003.20 The patient was treated successfully with off-
pump coronary bypass grafting, ascending aorta-to-
brachiocephalic and left common carotid bypass with a
bifurcated graft, and endovascular grafting of the aortic
arch with two Excluder thoracic grafts (W. L. Gore &
Assoc, Flagstaff, Ariz). In addition, Dietl et al21 in 2003
reported two cases in which there had been previous re-
placement of the ascending aorta for type A dissection with
aneurysmal dilatation of the arch. In these patients, they
performed a bypass from the ascending aortic graft to the
brachiocephalic trunk and left common carotid artery and
then performed endovascular grafting of the arch with
Gore stent-grafts.
Finally, Chuter et al22 in 2003 reported their use (land-
ing proximally in zone 0) of an interesting modular
branched stent-graft for endovascular repair of aortic arch
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cephalic trunk, provided that this vessel is of normal size.
Branched grafts are still in an experimental phase of devel-
opment, however, and we think their deployment will
require highly dedicated skills, and potentially entail central
nervous system complications.22
The proper selection of cases and exclusion of unsuit-
able cases was, in our opinion, the key to our encouraging
results with endovascular repair of aortic arch aneurysms,
with less peri-interventional morbidity and mortality and a
100% success rate. Such selection involves consideration of
aneurysmal configuration where cases with extensive aneu-rysmal disease without identifiable landing zones for en-
dograft attachment and seal are excluded. Also, exclusion
of patients with small and diseased access iliac arteries
resulted in nearly no major complications related to access
site. The revascularization of the supra-aortic vessels was
safely accomplished without CPB by means of aortic side-
clamping and controlled hypotension. Transposition of
epiaortic vessels also nearly abolishes the risk of embolic
stroke, which sometimes complicates aortic arch endograft
deployment.
The challenge of endovascular aortic arch repair is to
Fig 4. A, B, andC, Follow up computed tomography scan after
2 years shows complete exclusion of the thoracic aneurysm with
no endoleak.offer a durable seal and avoid late dislodgement of the
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the neck is usually of poor quality, so to further optimize
the proximal landing zone, we performed banding of the
ascending aorta distal to epiaortic vessel transposition.
Banding does not increase significantly the complexity of
the operation and its potential advantages are obvious. This
technique provides a good cylinder-shaped, fixed-diameter,
nonexpandable landing zone that is easily recognized by
radiograph where an endograft can be safely fixed (with or
without barbs) with little chance of subsequent leak, migra-
tion, or progression of disease. The intraoperative place-
ment of a radiopaque marker at the desired landing site
enabled precise deployment of the graft without the use of
additional contrast medium for aortography. Finally, the
normal difference in size between the ascending and de-
scending thoracic aorta makes it desirable to use a tapered
conical endograft, thus avoiding a problematic mismatch
between the diameter of the distal stent and that of a
tubular endograft suited to the ascending aorta.
CONCLUSION
Repair of aortic arch aneurysms by sequential transpo-
sition of the supra-aortic branches and endovascular stent-
graft placement appears to reduce the risk of such repair and
thereby possibly opens the indication for repair to more
critical patients. For good outcome, however, patient se-
lection should be done with utmost attention. Extended
application of this technique will enable safe and effective
treatment of a highly selected subgroup of patients with
aneurysms of the aortic arch by avoiding conventional
repair using deep hypothermia and circulatory arrest.
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aortic arch debranching
Stage I. During surgical “debranching” of the aortic arch and
relocation of the supra-aortic branches the following precautions
should be taken into account:
1. Shunts should be ready to manage possible electroencephalo-
graphic changes on carotid clamping.
2. The site of the bypass graft anastomosis to the ascending
aorta should be 5 cm proximal to the aneurysm.
3. Banding of the ascending aorta should be done without ten-
sion.
4. Ischemia of the left arm occurs rarely and carotid-subclavian
bypass or subclavian transposition is only performed at a later
stage if necessary. Primary reconstruction of the left subcla-
vian artery is, however, mandatory in patients with a left inter-
nal mammary bypass. The risk for cerebral and, particularly,
cerebellar infarction is significant in patients with a dominant
left vertebral artery and also motivates a bypass.Table III (online only). Specific technical aspects of
aortic arch endograft placement
Stage II. During endovascular stage of the procedures the following
precautions should be taken into account:
1. Thoracic stent-grafts remain bulky and 20F to 24F sheaths
are frequently required for large stent-grafts. Stenotic or tor-
tuous iliac arteries may hinder transfemoral insertion of a
large bore sheath; therefore, the iliac arteries should be as-
sessed routinely in such patients.
2. Cerebral emboli from massive manipulations in the arch, pe-
ripheral trash from a shaggy aorta, or thrombosis of iliac ves-
sels occluded by large-bore sheaths are a serious problem. We
therefore advocate high dose heparinization (activated clot-
ting time 300 seconds) during arch procedures. The effects
of heparin can instantly be reversed if necessary.
3. The accuracy of stent-graft deployment in the arch is facili-
tated by transient hypotension. Blood pressure of 80 mm
Hg is necessary for accurate and safe placement. Higher
blood pressure is likely to dislocate the stent-graft during de-
ployment. Close pre- and intraoperative collaboration with
the anesthetist is mandatory in such cases. Deployment by
retraction of the sheath needs to be initiated slightly beyond
the intended landing site. Most stent-grafts are pushed down-
stream to some extent during deployment. A partially released
stent-graft cannot be advanced safely, although distal reposi-
tioning remains possible. Multiple, repeat angiographies and
readjustments should be performed to place the stent-graft
accurately.
4. The mechanical forces of the aortic blood flow jeopardize
durable fixation of the device so banding, extended fixation
zones of 3 cm, and generous overlap between stent-graft
components 5 cm improves fixation and durability.
5. Firm fixation of the stent graft is particularly important in the
large and tortuous aneurysm. The temptation to extend the
stent-graft only a couple of centimeters beyond the ends of
the aneurysm should be avoided. The proximal fixation is par-
ticularly crucial and whenever possible, the stent graft should
be extended beyond the vertex of the arch.
